HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The HMGB1 receptor RAGE mediates ischemic brain damage.

Abstract
In ischemic stroke, the necrotic core is surrounded by a zone of inflammation, in which delayed cell death aggravates the initial insult. Here, we provide evidence that the receptor for advanced glycation end products (RAGE) functions as a sensor of necrotic cell death and contributes to inflammation and ischemic brain damage. The RAGE ligand high mobility group box 1 (HMGB1) was elevated in serum of stroke patients and was released from ischemic brain tissue in a mouse model of cerebral ischemia. A neutralizing anti-HMGB1 antibody and HMGB1 box A, an antagonist of HMGB1 at the receptor RAGE, ameliorated ischemic brain damage. Interestingly, genetic RAGE deficiency and the decoy receptor soluble RAGE reduced the infarct size. In vitro, expression of RAGE in (micro)glial cells mediated the toxic effect of HMGB1. Addition of macrophages to neural cultures further enhanced the toxic effect of HMGB1. To test whether immigrant macrophages in the ischemic brain mediate the RAGE effect, we generated chimeric mice by transplanting RAGE(-/-) bone marrow to wild-type mice. RAGE deficiency in bone marrow-derived cells significantly reduced the infarct size. Thus, HMGB1-RAGE signaling links necrosis with macrophage activation and may provide a target for anti-inflammatory therapy in stroke.
AuthorsSajjad Muhammad, Waleed Barakat, Stoyan Stoyanov, Sasidhar Murikinati, Huan Yang, Kevin J Tracey, Martin Bendszus, Grazisa Rossetti, Peter P Nawroth, Angelika Bierhaus, Markus Schwaninger
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 28 Issue 46 Pg. 12023-12031 (Nov 12 2008) ISSN: 1529-2401 [Electronic] United States
PMID19005067 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • HMGB1 Protein
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
Topics
  • Animals
  • Animals, Newborn
  • Antibodies (pharmacology)
  • Bone Marrow Transplantation (methods)
  • Brain Infarction (genetics, metabolism, physiopathology)
  • Brain Ischemia (genetics, metabolism, physiopathology)
  • Cell Death (genetics)
  • Cells, Cultured
  • Encephalitis (genetics, metabolism, physiopathology)
  • Female
  • HMGB1 Protein (antagonists & inhibitors, genetics, metabolism)
  • Humans
  • Macrophages (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia (drug effects, metabolism)
  • Necrosis (genetics, metabolism, physiopathology)
  • Nerve Degeneration (genetics, metabolism, physiopathology)
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic (genetics, metabolism)
  • Signal Transduction (drug effects, physiology)
  • Transplantation Chimera

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: